Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001354488-12-005172)

Filing Details

Accession Number:: 0001354488-12-005172
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-04 17:26:31
Reporting Period:: 2012-10-03

Filing Date:: 2012-10-04
Accepted Time:: 2012-10-04 17:26:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1024126	Pernix Therapeutics Holdings Inc.	PTX	Pharmaceutical Preparations (2834)	330724736

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413616	Cooper Michael Pearce	10003 Woodloch Forest Drive #950 The Woodlands TX 77380		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-10-03	833	$2.20	37,500	No	4	M	Direct
Common Stock	Acquisiton	2012-10-03	9,916	$4.20	47,416	No	4	M	Direct
Common Stock	Disposition	2012-10-03	10,749	$8.00	36,667	No	4	S	Direct
Common Stock	Acquisiton	2012-10-04	16,472	$4.20	47,139	No	4	M	Direct
Common Stock	Disposition	2012-10-04	16,472	$8.00	36,667	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/16/12.
The option, which represents a right to purchase a total of 42,500 shares, of which 41,667 were purchased prior to this date, became fully exercisable on 3/9/10.
The option, which represents a right to purchase a total of 137,500, shares became fully exercisable on 3/9/10.